Your browser doesn't support javascript.
loading
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
Wang, Chuan; Zainal, Nur Syafinaz; Chai, San Jiun; Dickie, James; Gan, Chai Phei; Zulaziz, Natasha; Lye, Bryan Kit Weng; Sutavani, Ruhcha V; Ottensmeier, Christian H; King, Emma V; Abraham, Mannil Thomas; Ismail, Siti Mazlipah Binti; Lau, Shin Hin; Kallarakkal, Thomas George; Mun, Kein Seong; Zain, Rosnah Binti; Abdul Rahman, Zainal Ariff; Thomas, Gareth J; Cheong, Sok Ching; Savelyeva, Natalia; Lim, Kue Peng.
Afiliación
  • Wang C; Head and Neck Cancer Center, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Zainal NS; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
  • Chai SJ; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
  • Dickie J; Cancer Sciences, University of Southampton, Southampton, United Kingdom.
  • Gan CP; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
  • Zulaziz N; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
  • Lye BKW; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
  • Sutavani RV; Cancer Sciences, University of Southampton, Southampton, United Kingdom.
  • Ottensmeier CH; Head and Neck Cancer Center, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • King EV; Cancer Sciences, University of Southampton, Southampton, United Kingdom.
  • Abraham MT; Ministry of Health Malaysia, Department of Oral & Maxillofacial Surgery, Tengku Ampuan Rahimah Hospital, Klang, Malaysia.
  • Ismail SMB; Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
  • Lau SH; Stomatology Unit, Cancer Research Centre, Institute for Medical Research, Kuala Lumpur, Malaysia.
  • Kallarakkal TG; Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
  • Mun KS; Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
  • Zain RB; Department of Pathology, Faculty of Medicine, University of Malaya, Selangor, Malaysia.
  • Abdul Rahman ZA; Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
  • Thomas GJ; Faculty of Dentistry, Malaysian Allied Health Sciences Academy (MAHSA) University, Selangor, Malaysia.
  • Cheong SC; Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University Teknologi Majlis Amanah Rakyat (MARA), Selangor, Malaysia.
  • Savelyeva N; Cancer Sciences, University of Southampton, Southampton, United Kingdom.
  • Lim KP; Cancer Immunology and Immunotherapy Unit, Cancer Research Malaysia, Selangor, Malaysia.
Front Immunol ; 12: 763086, 2021.
Article en En | MEDLINE | ID: mdl-34733290
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Vacunas de ADN / Carcinoma de Células Escamosas de Cabeza y Cuello / Inhibidores de Puntos de Control Inmunológico / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Vacunas de ADN / Carcinoma de Células Escamosas de Cabeza y Cuello / Inhibidores de Puntos de Control Inmunológico / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza